---
title: "VK2735 in Chronic weight management: Definition and etiology"
description: "Formulary evidence on VK2735 in Chronic weight management: Definition and etiology. Topics: Definition: World Health Organization body mass index thresholds for adults; Definition: obesity as a chronic, relapsing disease in the WHO guideline; Definition: clinical and preclinical obesity in the Lancet Diabetes and Endocrinology Commission; Definition: adiposity-based chronic disease in the AACE algorithm; 5 further topics. 9 evidence topics quoted from 6 sources."
canonical: "https://www.evicenter.com/drugs/vk2735--chronic-weight-management/product-information-and-disease-description/definition-and-etiology"
published: "2026-11-15T21:45:47-05:00"
modified: "2026-11-15T21:45:47-05:00"
---

# VK2735 in Chronic weight management: Definition and etiology

<a id="heading-2.2.1.1"></a>

## 2.2.1.1 Definition and Etiology

<a id="topic-2.2.1.1-1"></a>

### Definition: World Health Organization body mass index thresholds for adults

> “Obesity is a chronic disease affecting 1.1 billion people worldwide”
> “It is driven by complex interactions between environmental, social, biological and behavioural determinants.”
> “overweight is a BMI greater than or equal to 25; and obesity is a BMI greater than or equal to 30.”

Source: [WHO (2026)](https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight)

<a id="topic-2.2.1.1-2"></a>

### Definition: obesity as a chronic, relapsing disease in the WHO guideline

> “Obesity is a chronic, relapsing disease affecting over 1 billion people worldwide, driving substantial morbidity, mortality, and economic burden.”

Source: [Celletti et al. (2026)](https://pubmed.ncbi.nlm.nih.gov/41324410/)

<a id="topic-2.2.1.1-3"></a>

### Definition: clinical and preclinical obesity in the Lancet Diabetes and Endocrinology Commission

> “The Commission defines obesity as a condition characterised by excess adiposity, with or without abnormal distribution or function of adipose tissue, and with causes that are multifactorial and still incompletely understood.”
> “We define clinical obesity as a chronic, systemic illness characterised by alterations in the function of tissues, organs, the entire individual, or a combination thereof, due to excess adiposity.”
> “We define preclinical obesity as a state of excess adiposity with preserved function of other tissues and organs and a varying, but generally increased, risk of developing clinical obesity and several other non-communicable diseases (eg, type 2 diabetes, cardiovascular disease, certain types of cancer, and mental disorders).”

Source: [Rubino et al. (2025)](https://pmc.ncbi.nlm.nih.gov/articles/PMC11870235/)

<a id="topic-2.2.1.1-4"></a>

### Definition: adiposity-based chronic disease in the AACE algorithm

> “This 2025 algorithm for the medical care of adults with obesity underscores that ABCD is a complex, chronic disease that necessitates long-term treatment and care.”

Source: [Nadolsky et al. (2025)](https://pubmed.ncbi.nlm.nih.gov/40956256/)

<a id="topic-2.2.1.1-5"></a>

### Etiology: multifactorial causes and positive energy balance

> “Genetic, environmental, psychological, nutritional, and metabolic factors can induce alterations of the biological mechanisms that maintain normal mass, distribution, and function of adipose tissue, thus contributing to obesity.”
> “The accrual of body fat occurs as a function of positive energy balance, whereby the rate of appearance of macronutrients exceeds that of disappearance.”
> “The global rise in the prevalence of obesity is driven by social and environmental factors, in particular easy access to energy-dense, heavily marketed, processed foods that are palatable and inexpensive.”

Source: [Rubino et al. (2025)](https://pmc.ncbi.nlm.nih.gov/articles/PMC11870235/)

<a id="topic-2.2.1.1-6"></a>

### Etiology: heritability and monogenic forms

> “Evidence from studies of families, twins, and adopted children shows that at least 40–70% of the variation in body weight is explainable by genetic factors (heritability).”
> “Mutations in single genes, chromosomal regions, and copy number variants can cause severe obesity, pointing to biological pathways that regulate energy intake, energy expenditure, and body weight.”
> “In particular, disruption of genes in the leptin-melanocortin pathway alters eating behaviour by increasing hunger, decreasing satiety, activating food reward cues, and increasing the preference for dietary fat.”

Source: [Rubino et al. (2025)](https://pmc.ncbi.nlm.nih.gov/articles/PMC11870235/)

<a id="topic-2.2.1.1-7"></a>

### Etiology: obesogenic environments and biological susceptibility

> “Obesity is a chronic disease resulting from complex interactions between environmental and psychosocial influences and biological susceptibility.”
> “The global health challenge of obesity is driven by increasingly obesogenic environments that limit access to healthy, affordable and sustainably produced foods; constrain opportunities for safe physical activity; and are shaped by market forces and inadequate legal and regulatory frameworks.”
> “Obesity is characterized by dysregulation of neurobiological and metabolic pathways involved in appetite, energy balance and adipose tissue function, with genetic variation influencing individual susceptibility.”

Source: [WHO (2026)](https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight)

<a id="topic-2.2.1.1-8"></a>

### Etiology: diet and environmental exposures

> “Thus, habitual consumption of highly palatable and energy-dense diets predispose to excess weight gain irrespective of macronutrient content.”
> “Beyond diet, environmental factors ranging from socioeconomic status to chemical exposures to sedentary lifestyle can confer obesity risk.”

Source: [Schwartz et al. (2017)](https://pmc.ncbi.nlm.nih.gov/articles/PMC5546881/)

<a id="topic-2.2.1.1-9"></a>

### Etiology: health behaviors, stress, health conditions, and medications

> “Obesity is a complex and costly chronic disease influenced by many factors. These factors include health behaviors, stress, health conditions and medications, genes, and people's environment.”
> “Some health conditions may lead to excess weight gain, obesity, or insulin resistance. These conditions include Cushing syndrome, polycystic ovary syndrome, or underactive thyroid.”
> “Some medications may also cause weight gain by disrupting the brain's signals for hunger or through other mechanisms.”
> “In specific, rare, single-gene disorders, genes can directly cause obesity. Examples of these disorders are Bardet-Biedl syndrome and Prader-Willi syndrome.”

Source: [CDC Risk Factors for Obesity (2025)](https://www.cdc.gov/obesity/risk-factors/risk-factors.html)

## Related pages
- [VK2735: Chronic weight management](https://www.evicenter.com/drugs/vk2735--chronic-weight-management) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management.md)
- [VK2735 in Chronic weight management: Terms and abbreviations](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/terms-and-abbreviations.md)
- [VK2735: Chronic weight management](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/executive-summary) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/executive-summary.md)
- [VK2735 in Chronic weight management: Product information and disease description](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/product-information-and-disease-description.md)
- [VK2735 in Chronic weight management: Clinical evidence](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/clinical-evidence.md)
- [VK2735 in Chronic weight management: Economic information and modeling report](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/economics) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/economics.md)
- [VK2735 in Chronic weight management: References](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/references) · [Markdown](https://www.evicenter.com/drugs/vk2735--chronic-weight-management/references.md)
